Stock Analysis on Net

Bristol-Myers Squibb Co. (NYSE:BMY)

Analysis of Long-term (Investment) Activity Ratios

Microsoft Excel LibreOffice Calc

Long-term Activity Ratios (Summary)

Bristol-Myers Squibb Co., long-term (investment) activity ratios

Microsoft Excel LibreOffice Calc
Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016
Net fixed asset turnover 7.22 4.18 4.49 4.15 3.90
Net fixed asset turnover (including operating lease, right-of-use asset) 6.30 3.76 4.49 4.15 3.90
Total asset turnover 0.36 0.20 0.64 0.62 0.58
Equity turnover 1.12 0.51 1.61 1.77 1.20

Based on: 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31).

Long-term activity ratio Description The company
Net fixed asset turnover An activity ratio calculated as total revenue divided by net fixed assets. Bristol-Myers Squibb Co. net fixed asset turnover ratio deteriorated from 2018 to 2019 but then improved from 2019 to 2020 exceeding 2018 level.
Net fixed asset turnover (including operating lease, right-of-use asset) An activity ratio calculated as total revenue divided by net fixed assets (including operating lease, right-of-use asset). Bristol-Myers Squibb Co. net fixed asset turnover ratio (with operating lease, right-of-use asset) deteriorated from 2018 to 2019 but then improved from 2019 to 2020 exceeding 2018 level.
Total asset turnover An activity ratio calculated as total revenue divided by total assets. Bristol-Myers Squibb Co. total asset turnover ratio deteriorated from 2018 to 2019 but then slightly improved from 2019 to 2020.
Equity turnover An activity ratio calculated as total revenue divided by shareholders’ equity. Bristol-Myers Squibb Co. equity turnover ratio deteriorated from 2018 to 2019 but then improved from 2019 to 2020 not reaching 2018 level.

Net Fixed Asset Turnover

Bristol-Myers Squibb Co., net fixed asset turnover calculation, comparison to benchmarks

Microsoft Excel LibreOffice Calc
Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016
Selected Financial Data (US$ in millions)
Revenues 42,518  26,145  22,561  20,776  19,427 
Property, plant and equipment 5,886  6,252  5,027  5,001  4,980 
Long-term Activity Ratio
Net fixed asset turnover1 7.22 4.18 4.49 4.15 3.90
Benchmarks
Net Fixed Asset Turnover, Competitors2
Abbott Laboratories 3.83 3.97 4.04 3.60 3.66
Anthem Inc. 34.69 32.92 33.40 40.95 42.57
Becton, Dickinson & Co. 2.89 3.06 2.97 2.61 3.20
CVS Health Corp. 21.25 21.24 17.09 17.95 17.45
Danaher Corp. 6.83 7.78 7.92 7.47 7.17
Edwards Lifesciences Corp. 3.14 4.10 4.29 5.05 5.11
HCA Healthcare Inc. 2.22 2.26 2.36 2.44 2.54
Intuitive Surgical Inc. 2.76 3.52 4.59 5.10 5.90
Medtronic PLC 5.99 6.54 6.51 6.81 5.96
Stryker Corp. 5.21 5.80 5.94 6.30 7.22
UnitedHealth Group Inc. 29.64 27.60 26.59 28.54 31.18
Net Fixed Asset Turnover, Sector
Health Care Equipment & Services 10.47 10.18 9.77 9.97 10.25
Net Fixed Asset Turnover, Industry
Health Care 7.14 7.21 7.01 6.96 7.16

Based on: 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31).

1 2020 Calculation
Net fixed asset turnover = Revenues ÷ Property, plant and equipment
= 42,518 ÷ 5,886 = 7.22

2 Click competitor name to see calculations.

Long-term activity ratio Description The company
Net fixed asset turnover An activity ratio calculated as total revenue divided by net fixed assets. Bristol-Myers Squibb Co. net fixed asset turnover ratio deteriorated from 2018 to 2019 but then improved from 2019 to 2020 exceeding 2018 level.

Net Fixed Asset Turnover (including Operating Lease, Right-of-Use Asset)

Bristol-Myers Squibb Co., net fixed asset turnover (including operating lease, right-of-use asset) calculation, comparison to benchmarks

Microsoft Excel LibreOffice Calc
Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016
Selected Financial Data (US$ in millions)
Revenues 42,518  26,145  22,561  20,776  19,427 
 
Property, plant and equipment 5,886  6,252  5,027  5,001  4,980 
Operating lease right-of-use assets 859  704  —  —  — 
Property, plant and equipment (including operating lease, right-of-use asset) 6,745  6,956  5,027  5,001  4,980 
Long-term Activity Ratio
Net fixed asset turnover (including operating lease, right-of-use asset)1 6.30 3.76 4.49 4.15 3.90
Benchmarks
Net Fixed Asset Turnover (including Operating Lease, Right-of-Use Asset), Competitors2
Abbott Laboratories 3.42 3.56 4.04 3.60 3.66
Anthem Inc. 29.26 27.82 33.40 40.95 42.57
Becton, Dickinson & Co. 2.70 3.06 2.97 2.61 3.20
CVS Health Corp. 8.04 7.77 17.09 17.95 17.45
Danaher Corp. 5.30 5.84 7.92 7.47 7.17
Edwards Lifesciences Corp. 2.95 3.81 4.29 5.05 5.11
HCA Healthcare Inc. 2.04 2.09 2.36 2.44 2.54
Intuitive Surgical Inc. 2.66 3.32 4.59 5.10 5.90
Medtronic PLC 5.02 6.54 6.51 6.81 5.96
Stryker Corp. 4.52 5.04 5.94 6.30 7.22
UnitedHealth Group Inc. 19.55 18.97 26.59 28.54 31.18
Net Fixed Asset Turnover (including Operating Lease, Right-of-Use Asset), Sector
Health Care Equipment & Services 7.50 7.35 9.77 9.97 10.25
Net Fixed Asset Turnover (including Operating Lease, Right-of-Use Asset), Industry
Health Care 5.75 5.83 7.01 6.96 7.16

Based on: 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31).

1 2020 Calculation
Net fixed asset turnover (including operating lease, right-of-use asset) = Revenues ÷ Property, plant and equipment (including operating lease, right-of-use asset)
= 42,518 ÷ 6,745 = 6.30

2 Click competitor name to see calculations.

Long-term activity ratio Description The company
Net fixed asset turnover (including operating lease, right-of-use asset) An activity ratio calculated as total revenue divided by net fixed assets (including operating lease, right-of-use asset). Bristol-Myers Squibb Co. net fixed asset turnover ratio (with operating lease, right-of-use asset) deteriorated from 2018 to 2019 but then improved from 2019 to 2020 exceeding 2018 level.

Total Asset Turnover

Bristol-Myers Squibb Co., total asset turnover calculation, comparison to benchmarks

Microsoft Excel LibreOffice Calc
Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016
Selected Financial Data (US$ in millions)
Revenues 42,518  26,145  22,561  20,776  19,427 
Total assets 118,481  129,944  34,986  33,551  33,707 
Long-term Activity Ratio
Total asset turnover1 0.36 0.20 0.64 0.62 0.58
Benchmarks
Total Asset Turnover, Competitors2
Abbott Laboratories 0.48 0.47 0.46 0.36 0.40
Anthem Inc. 1.39 1.33 1.28 1.26 1.29
Becton, Dickinson & Co. 0.32 0.33 0.30 0.32 0.49
CVS Health Corp. 1.16 1.15 0.99 1.94 1.88
Danaher Corp. 0.29 0.29 0.42 0.39 0.37
Edwards Lifesciences Corp. 0.61 0.67 0.70 0.60 0.66
HCA Healthcare Inc. 1.09 1.14 1.19 1.19 1.23
Intuitive Surgical Inc. 0.39 0.46 0.47 0.54 0.42
Medtronic PLC 0.32 0.34 0.33 0.30 0.29
Stryker Corp. 0.42 0.49 0.50 0.56 0.55
UnitedHealth Group Inc. 1.30 1.38 1.48 1.44 1.50
Total Asset Turnover, Sector
Health Care Equipment & Services 0.84 0.83 0.88 0.96 1.00
Total Asset Turnover, Industry
Health Care 0.64 0.65 0.67 0.66 0.68

Based on: 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31).

1 2020 Calculation
Total asset turnover = Revenues ÷ Total assets
= 42,518 ÷ 118,481 = 0.36

2 Click competitor name to see calculations.

Long-term activity ratio Description The company
Total asset turnover An activity ratio calculated as total revenue divided by total assets. Bristol-Myers Squibb Co. total asset turnover ratio deteriorated from 2018 to 2019 but then slightly improved from 2019 to 2020.

Equity Turnover

Bristol-Myers Squibb Co., equity turnover calculation, comparison to benchmarks

Microsoft Excel LibreOffice Calc
Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016
Selected Financial Data (US$ in millions)
Revenues 42,518  26,145  22,561  20,776  19,427 
Total Bristol-Myers Squibb Company shareholders’ equity 37,822  51,598  14,031  11,741  16,177 
Long-term Activity Ratio
Equity turnover1 1.12 0.51 1.61 1.77 1.20
Benchmarks
Equity Turnover, Competitors2
Abbott Laboratories 1.06 1.03 1.00 0.89 1.02
Anthem Inc. 3.64 3.25 3.20 3.36 3.35
Becton, Dickinson & Co. 0.72 0.82 0.76 0.93 1.64
CVS Health Corp. 3.86 4.00 3.33 4.90 4.82
Danaher Corp. 0.56 0.59 0.71 0.70 0.73
Edwards Lifesciences Corp. 0.96 1.05 1.19 1.16 1.13
HCA Healthcare Inc. 90.09
Intuitive Surgical Inc. 0.45 0.54 0.56 0.66 0.47
Medtronic PLC 0.57 0.61 0.59 0.59 0.55
Stryker Corp. 1.10 1.16 1.16 1.25 1.19
UnitedHealth Group Inc. 3.90 4.17 4.35 4.19 4.81
Equity Turnover, Sector
Health Care Equipment & Services 2.27 2.22 2.33 2.53 2.62
Equity Turnover, Industry
Health Care 1.91 1.93 1.93 1.83 1.81

Based on: 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31).

1 2020 Calculation
Equity turnover = Revenues ÷ Total Bristol-Myers Squibb Company shareholders’ equity
= 42,518 ÷ 37,822 = 1.12

2 Click competitor name to see calculations.

Long-term activity ratio Description The company
Equity turnover An activity ratio calculated as total revenue divided by shareholders’ equity. Bristol-Myers Squibb Co. equity turnover ratio deteriorated from 2018 to 2019 but then improved from 2019 to 2020 not reaching 2018 level.